Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
Journal of the American Chemical Society|July 18, 2001
Rational design and assembly of M(2)M'(3)L(6) supramolecular clusters with C(3h) symmetry by exploiting incommensurate symmetry numbersX Sun, D W Johnson, D L Caulder, et al.Radiation Research|July 1, 1984
Specific sequestering agents for the actinides: 10. Enhancement of 238Pu elimination from mice by poly(catechoylamide) ligandsP W Durbin, N Jeung, E S Jones, et al.Human & Experimental Toxicology|April 1, 1996
Octadentate catecholamide ligands for Pu(IV) based on linear or preorganized molecular backbonesP W Durbin, B Kullgren, N Jeung, et al.Inorganic Chemistry|January 11, 2001
Syntheses and relaxation properties of mixed gadolinium hydroxypyridinonate MRI contrast agentsS M Cohen, J Xu, E Radkov, et al.Journal of Pharmaceutical Sciences|March 29, 2000
The hexadentate hydroxypyridinonate TREN-(Me-3,2-HOPO) is a more orally active iron chelator than its bidentate analogueR A Yokel, A M Fredenburg, P W Durbin, et al.Journal of Bacteriology|August 1, 1986
Escherichia coli iron enterobactin uptake monitored by Mössbauer spectroscopyB F Matzanke, D J Ecker, T S Yang, et al.Journal of Magnetic Resonance Imaging : JMRI|January 1, 1992
Ionic versus nonionic MR imaging contrast media: operational definitionsC A Chang, P F Sieving, A D Watson, et al.International Journal of Radiation Biology|February 9, 2000
Efficacy of 3,4,3-LIHOPO for reducing neptunium retention in the rat after simulated wound contaminationF Paquet, B Montègue, E Ansoborlo, et al.Radiation Protection Dosimetry|October 7, 2003
Octadentate hydroxypyridinonate (HOPO) ligands for plutonium (i.v.): pharmacokinetics and oral efficacyP W Durbin, B Kullgren, J Xu, et al.International Journal of Radiation Biology|October 1, 1993
Efficacy of 3,4,3-LIHOPO for reducing the retention of 238Pu in rat after inhalation of the tributyl phosphate complexJ L Poncy, G Rateau, R Burgada, et al.Pageof 6